MedPath

Innovations in HIV Testing (TI)

Not Applicable
Completed
Conditions
Human Immunodeficiency Virus
Registration Number
NCT03271424
Lead Sponsor
University of North Carolina, Chapel Hill
Brief Summary

The investigators propose to improve HIV prevention and care through expanding HIV testing options to include self-testing for young women, their peers and their sex partners, and by facilitating linkage to care.

Detailed Description

Study Description Brief Summary: The investigators propose to improve HIV prevention and care through expanding HIV testing options to include self-testing for young women, their peers and their sex partners, and by facilitating linkage to care.

Detailed Description: The investigators propose to improve HIV prevention and care through expanding HIV testing options to include self-testing for young women, their peers and their sex partners, and by facilitating linkage to care. In this study the investigators proposed two phases. The first phase, explained in this submission, is formative and involved two parts: 1) conducting formative qualitative research to understand perceptions of HIV testing and HIV self-testing in the study population and 2) conducting observed HIV self-testing to better understand any challenges with self-testing and the materials needed to make the process clear. The second phase of the study is a randomized controlled trial where the investigators will randomize approximately 400 young women to receive either 1) CHOICE of self-testing or clinic-based HIV Counseling and Testing (HCT) or 2) clinic based HCT. Once young women have been randomized, they will be asked to recruit up to 4 peers or male sex partners to test with the method of their randomization group.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
95
Inclusion Criteria
  • Females and males aged 18 - 24
  • Able and willing to provide informed consent
  • Residing in the selected villages

Observation Inclusion Criteria:

  • Females and males aged 18 -24
  • Able and willing to provide informed consent
  • Residing in the selected villages
  • Not known to be HIV positive (not reporting a previous positive test)
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Qualitative Summaries of Participant Experience in Focus Group Discussions6 months post study start

Qualitative Summaries for recruitment of peers/sex partners, issues related to privacy and spaces for testing, options for post-test counseling, optimizing return visits, and preferences for contact

Quantitative Summaries of Participants Experience in Observation Sessions12 month post study start

Frequency counts of clarity of instructions, comfort using the test, confidence in test result, difficulty performing the test and reading results

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit

🇿🇦

Agincourt, Mpumalanga, South Africa

Medical Research Council/Wits University Rural Public Health and Health Transitions Research Unit
🇿🇦Agincourt, Mpumalanga, South Africa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.